en · de · es · fr · pt
tb-500-notes.peptides9002.com › News › Thymosin Beta-4 Fragment Overview — 2026 Update

Thymosin Beta-4 Fragment Overview — 2026 Update

By Editorial Desk · published 2026-03-18 · last reviewed 2026-05-08 · News

This is a working overview of freeze-thaw cycling, written for readers who want more than a one-paragraph summary but less than a textbook.

This page was last updated on 2026-05-08 and is reviewed periodically as new material appears.

Thymosin Beta-4 Fragment Overview

The compound circulates in the literature as a research reagent rather than an approved therapeutic. Regulatory agencies in several countries have not authorized it for medical use, and sporting bodies list related thymosin beta-4 peptides among prohibited substances. Suppliers typically market it with a purity figure and a certificate of analysis, while peer-reviewed clinical reports remain sparse. Discussions therefore often separate laboratory findings from anecdotal reports, and reviewers tend to note the small size and methodological limits of the available studies.

TB-500 refers to a synthetic peptide fragment derived from the actin-binding region of thymosin beta-4, a protein present in most mammalian cells. The full protein contains forty-three amino acids, while the commonly sold fragment is a much shorter acetylated sequence, often cited as LKKTETQ. The fragment retains part of the actin-binding motif but lacks the remainder of the parent protein. Material sold under this name is usually lyophilized powder intended for laboratory research, and it is not a finished pharmaceutical product.

Proposed activity centers on actin sequestration and on the movement of cells during repair processes. In cell culture and animal models, the fragment has been associated with migration, tube formation, and tissue remodeling. These observations are frequently described as preliminary, because most published work uses rodent or in vitro systems rather than controlled human trials. Whether the short fragment reproduces the effects of the full protein remains an open question, and the relationship between dose, route, and measured outcome is not well characterized.

Handling, Storage, and Quality Control

Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.

Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.

Tb-500 at a glance

PropertyValueNotes
AppearanceWhite to off-white powderLyophilized solid as supplied
Water solubilitySolubleDissolves in aqueous media
Typical storage temperature-20 °CDry powder, desiccated, protected from light
Typical analytical methodRP-HPLC with mass spectrometryPurity from peak area; mass for identity
Common synonymsTβ4 fragment; thymosin beta-4 fragmentNaming varies by supplier and catalogue

TB-500 Identity and Naming Background

Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.

TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.

Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.

Related pages on this site

Handling, Storage and Quality Checks

Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.

Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.

Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.

Background from the literature

=== Cornell University === In May 2005, a disco ball was found affixed to the top of McGraw Tower. Due to safety concerns about the glass shattering, the disco ball was removed the next day by crane, costing the university $20,000-$25,000.

In those on insulin, routinely checking blood sugar levels (such as through a continuous glucose monitor) is advised; however, this may not be needed in those who are not on insulin therapy. Bariatric surgery often improves diabetes in those who are obese. Rates of type 2 diabetes have increased markedly since 1960 in parallel with obesity. As of 2015, there were approximately 392 million people diagnosed with the disease compared to around 30 million in 1985. Typically, it begins in middle or older age, although rates of type 2 diabetes are increasing in young people. Type 2 diabetes is associated with a ten-year-shorter life expectancy. Diabetes was one of the first diseases ever described, dating back to an Egyptian manuscript from c. 1500 BCE. Two types of diabetes were identified in 400–500 CE, one type associated with youth (now identified as type 1) and the other associated with being overweight (now identified as type 2). The importance of insulin in the disease was determined in the 1920s.

Open water fish are usually streamlined like torpedoes to minimize turbulence as they move through the water. Reef fish live in a complex, relatively confined underwater landscape and for them, manoeuvrability is more important than speed, and many of them have developed bodies which optimize their ability to dart and change direction. Many have laterally compressed bodies (flattened from side to side) allowing them to fit into fissures and swim through narrow gaps; some use their pectoral fins for locomotion and others undulate their dorsal and anal fins. Some fish have grown dermal (skin) appendages for camouflage; the prickly leather-jacket is almost invisible among the seaweed it resembles and the tasselled scorpionfish invisibly lurks on the seabed ready to ambush prey. Some like the foureye butterflyfish have eyespots to startle or deceive, while others such as lionfish have aposematic coloration to warn that they are toxic or have venomous spines. Flatfish are demersal fish (bottom-feeding fish) that show a greater degree of asymmetry than any other vertebrates. The larvae are at first bilaterally symmetrical but they undergo metamorphosis during the course of their development, with one eye migrating to the other side of the head, and they simultaneously start swimming on their side. This has the advantage that, when they lie on the seabed, both eyes are on top, giving them a broad field of view. The upper side is usually speckled and mottled for camouflage, while the underside is pale. Some teleosts are parasites.

=== Recreational drug use === Subcutaneous injection may also be used by people to (self-) administer recreational drugs. This can be referred to as skin popping. In some cases, the administration of illicit drugs in this way is associated with unsafe practices leading to infections and other adverse effects. In rare cases, this results in serious side effects such as AA amyloidosis. Recreational drugs reported to be administered subcutaneously have included cocaine, mephedrone, and amphetamine derivatives such as PMMA.

== Student body and campus == As of 2025, Einstein had 789 medical students according to U.S. News & World Report. Admission to Einstein's MD program is highly selective, with an acceptance rate of 1.85% in 2024. All students are awarded the full-tuition Gottesman Scholarship. The average post-scholarship cost of attendance for all four years is $138,000. New York residents comprise 44 percent of MD students. Einstein offers housing for students and postdoctoral researchers. Student housing consists of three 28-story towers built in 1970. Living spaces include studios, three-bedroom penthouses, and one-, two-, or three-bedroom apartments. The campus also hosts a recreational facility, the Falk Center, that houses a gym, pool, and courts for basketball, racquetball, and squash. An underground parking garage is located on campus.

Sources: en.wikipedia.org

Further detail

=== Other uses === Prostanoids, including alprostadil, do not reduce the risk of limb amputation but may offer a slight improvement in rest-pain and leg ulcer healing in persons with critical limb ischemia. Preventative administration of alprostadil may reduce the risk of kidney injury (specifically contrast-induced nephropathy) in persons having cardiac angiography or percutaneous coronary intervention. Lubiprostone is a PGE1 derivative used to treat chronic constipation. It is taken orally. Common side effects include diarrhea, vomiting, and abdominal pain.

=== 1955 === February 24: The Baghdad Pact is founded by Iran, Iraq, Pakistan, Turkey, and the United Kingdom. It is committed to resisting Communist expansion in the Middle East. March: Soviet aid to Syria begins. The Syrians will remain allies of the Soviets until the end of the Cold War. April 18: The Asia-Africa Conference (also known as the Bandung Conference) is first held in Bandung, Indonesia. April: The Non-Aligned Movement is pioneered by Jawaharlal Nehru of India, Sukarno of Indonesia, Tito of Yugoslavia, Gamal Abdel Nasser of Egypt and Kwame Nkrumah of Ghana (then known as the Gold Coast). This movement is designed to be a bulwark against the 'dangerous polarization' of the world at that time and to restore the balance of power with smaller nations. May 5: The Allies end the military occupation of West Germany. May 6: The United States begins formal diplomatic relations with West Germany, followed soon after by the United Kingdom and France. May 9: West Germany joins NATO and begins rearmament. May 14: The Warsaw Pact is founded in Eastern Europe and includes East Germany, Czechoslovakia, Poland, Hungary, Romania, Albania, Bulgaria, and the Soviet Union. It acts as the Communist military counterpart to NATO. May 15: The Austrian State Treaty is signed by the Allied powers. July 18: President Dwight D. Eisenhower of the United States, Prime Minister Anthony Eden of the United Kingdom, Premier Nikolai A. Bulganin of the Soviet Union, and Prime Minister Edgar Faure of France, known as the 'Big Four', attend the Geneva Summit.

===== Epikeratophakia ===== Rarely, a nonpenetrating keratoplasty known as an epikeratophakia (or epikeratoplasty) may be performed in cases of keratoconus. The corneal epithelium is removed and a lenticule of donor cornea is grafted on top of it. The procedure requires a greater level of skill on the part of the surgeon, and is less frequently performed than a penetrating keratoplasty, as the outcome is generally less favorable. However, it may be seen as an option in a number of cases, particularly for young people.

== Chemistry == Insulin icodec is an acylated analogue of human insulin. Like human insulin, it consists of two peptide chains linked by disulfide bonds. It was engineered with three amino acid substitutions, A14E, B16H, and B25H, and a C20 icosane fatty diacid-containing side chain attached at lysine B29 through a hydrophilic linker. This side chain imparts strong, reversible binding to albumin. The amino acid substitutions provide molecular stability and attenuate insulin receptor binding, contributing to its longer duration of action.

=== Production and secretion === The physiological stimulus for secretion of vasopressin is increased osmolality of the plasma, monitored by the hypothalamus. A decreased arterial blood volume, (such as can occur in cirrhosis, nephrosis, and heart failure), stimulates secretion, even in the face of decreased osmolality of the plasma: it supersedes osmolality, but with a milder effect. In other words, the unloading of arterial baroreceptors when the arterial blood volume is low stimulates vasopressin secretion despite the presence of hypoosmolality (hyponatremia). The AVP that is measured in peripheral blood is almost all derived from secretion from the posterior pituitary gland (except in cases of AVP-secreting tumours). Vasopressin is produced by magnocellular neurosecretory neurons in the paraventricular nucleus of hypothalamus (PVN) and supraoptic nucleus (SON). It then travels down the axon through the infundibulum within neurosecretory granules that are found within Herring bodies, localized swellings of the axons and nerve terminals. These carry the peptide directly to the posterior pituitary gland, where it is stored until released into the blood. There are other sources of AVP, beyond the hypothalamic magnocellular neurons. For example, AVP is also synthesized by parvocellular neurosecretory neurons of the PVN, transported and released at the median eminence, from which it travels through the hypophyseal portal system to the anterior pituitary, where it stimulates corticotropic cells synergistically with CRH to produce ACTH (by itself it is a weak secretagogue).

Sources: en.wikipedia.org

Frequently asked questions

What is TB-500?

TB-500 is a name used for a short synthetic peptide fragment taken from the actin-binding region of thymosin beta-4. Material sold under this label is usually a lyophilized powder supplied for laboratory research rather than a licensed medicine. The commonly cited sequence is LKKTETQ.

How does it differ from full thymosin beta-4?

The parent protein contains forty-three amino acids, while the fragment carries only a short motif from one region. The fragment can interact with actin in vitro, but it does not include the rest of the protein structure. Whether the shorter molecule behaves the same way in living systems is not settled.

Is human evidence available?

Published controlled human studies are scarce, and most activity reports come from cell culture or animal models. Reviews often describe the evidence base as limited and methodologically uneven. Open questions include the relationship between route, dose, and measured outcomes.

How is lyophilized TB-500 stored?

The dry powder is normally kept at -20 °C, protected from light and moisture. Reconstituted solutions are often divided into aliquots and stored at -80 °C to reduce freeze-thaw damage.

Network